A novel strategy for cancer gene therapy: RNAi

Chinese Science Bulletin

Volumn 51, Issue 10, 2006, Pages 1145-1151

  Pan, Qiuwei ^a   Cai, Rong ^a   Liu, Xinyuan ^a,b   Qian, Cheng ^a,c  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cancer gene therapy; RNAi; Strategy

Indexed keywords

EID: 33748929712     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-006-1145-x     Document Type: Review

References (35)

1. Elbashir S M, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411:494-498
2. Kim D H, Longo M, Han Y, et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol, 2004, 22:321-325
3. Brummelkamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296:550-553
4. Sui O, Soohoo C, Affar E, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA, 2002, 99: 5515-5520
5. Bologna J C, Dorn G, Natt F, et al. Linear polyethylenimine as a tool for comparative studies of antisense and short double-stranded RNA oligonucleotides. Nucleosides Nucleotides Nucleic Acids, 2003, 22(5-8): 1729-1731
6. Schiffelers R M, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res, 2004, 32(19): e149
7. Devroe E, Silver P A. Retrovirus-delivered siRNA. BMC Biotechnol, 2002, 2: 15
8. Abbas-Terki T, Blanco-Bose W, Deglon N. Lentiviral-mediated RNA interference. Hum Gene Ther, 2002, 13(18): 2197-2201
9. Tomar R S, Matta H, Chaudhary P M. Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene, 2003, 22(36): 5712-5715
10. Rubinson D A, Dillon C P, Kwiatkowski A V, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet, 2003, 33: 401-406
11. Hommel J D, Sears R M, Georgescu D, et al. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med, 3003, 9:1539-1544
12. Nicholson L J, Philippe M, Paine A J, et al. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Ther, 2005, 11(4): 638-644
13. Swisher S G, Roth J A, Nemunaitis J, et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst, 1999, 91(9): 763-771
14. Carette J E, Overmeer R M, Schagen F H E, et al. Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells, Cancer Res, 2004, 64: 2663-2667.
15. Chu R L, Post D E, Khuri F R, et al. Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin Cancer Res, 2004, 10(16): 5299-5312
16. Liu X Y, Gu J F, Shi W F. Targeting gene-virotherapy for cancer. Acta Biochim Biophys Sin (Shanghai), 2005, 37(9): 581-587
17. Pei Z, Chun L, Zou W, et al. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology, 2004, 39(5): 1371-1381
18. Zou W, Luo C, Zhang Z. Novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent. Oncogene, 2004, 23(2): 457-464
19. Kanerva A, Zinn K R, Chaudhuri T R, et al. Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol Ther, 2003, 8:449-558
20. Brummelkamp T R, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell, 2002, 2:243-247
21. Fleming J B, Shen G L, Holloway S E, et al. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: Justification for K-ras-directed therapy. Mol Cancer Res, 2005, 3(7): 413-423
22. Wang Y H, Liu S, Zhang G, et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res, 2005, 7(2): R220-228
23. Li K, Lin S, Brunicardi F C, et al. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res, 2003, 63: 3593-3597
24. Martin-Lluesma S, Stucke V M, Nigg E A. Role of Heel in spindle checkpoint surviving and kinetochore recruitment of Mad1/Mad2. Science, 2002, 297: 2267-2270
25. Chen Z, Varney M L, Backora M W, et al. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res, 2005, 65(19): 9004-9011
26. Shen J, Samul R, Silva R L, et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther, 2006, 13(3): 225-234
27. Amantana A, London C A, Iversen P L, et al. X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther, 2004, 3(6): 699-707
28. Stierle V, Laigle A, Jolles B. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. Biochem Pharmacol, 2005, 70(10): 1424-1430
29. Pichler A, Zelcer N, Prior J L. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein. Clin Cancer Res, 2005, 11(12): 4487-4494
30. Kami K, Doi R, Koizumi M, et al. Downregulation of surviving by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery, 2005, 138(2): 299-305
31. Martinez L A, Naguibneva I, Lehrmann H, et al. Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc Natl Acad Sci USA, 2002, 99(23): 14849-14854
32. Yoontae L, Minju K, Jinju H, et al. MicroRNA genes are transcribed by RNA polymerasell. EMBO J, 2004, 23(20): 4051-4060
33. Stegmeier F, Hu G, Riokles R J, et al. A lentiviral microRNA-based System for single-copy polymerase II regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA, 2005, 102(37): 13212-13217
34. Wang L, Hernandez-Alcoceba R, Shankar V. Prolonged and inducible transgene expression in the liver using gutless adenovirus: A potential therapy for liver cancer. Gastroenterology, 2004, 126(1): 278-289
35. Cole C, Qiao J, Kottke T, et al. Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells. Nat Med, 2005, 11(10): 1073-1081